Discrimination between human leukocyte antigen class I-bound and co-purified HIV-derived peptides in immunopeptidomics workflows

Discrimination between human leukocyte antigen class I-bound and co-purified HIV-derived peptides in immunopeptidomics workflows

Elucidation of novel peptides presented by human leukocyte antigen (HLA) class I alleles by immunopeptidomics constitutes a powerful approach that can inform the rational design of CD8+ T cell inducing vaccines to control infection with pathogens such as human immunodeficiency virus type 1 (HIV-1) o...

Full description

Bibliographic Details
Main Authors:	Partridge, T, Nicastri, A, Kliszczak, A, Yindom, L, Kessler, B, Ternette, N, Borrow, P
Format:	Journal article
Published:	Frontiers Media 2018

Similar Items

Discrimination Between Human Leukocyte Antigen Class I-Bound and Co-Purified HIV-Derived Peptides in Immunopeptidomics Workflows
by: Thomas Partridge, et al.
Published: (2018-04-01)

Mass spectrometry–based identification of MHC-bound peptides for immunopeptidomics
by: Purcell, A, et al.
Published: (2019)

Mining the Immunopeptidome for Antigenic Peptides in Cancer
by: Ricardo A. León-Letelier, et al.
Published: (2022-10-01)

The Human Leukocyte Antigen Class II Immunopeptidome of the SARS-CoV-2 Spike Glycoprotein
by: Michael D. Knierman, et al.
Published: (2020-12-01)

Immunopeptidomic profiling of HLA-A2-positive triple negative breast cancer identifies potential immunotherapy target antigens
by: Ternette, N, et al.
Published: (2018)

Immunopeptidomics special issue
by: Ternette, N, et al.
Published: (2018)

Deciphering Human Leukocyte Antigen Susceptibility Maps From Immunopeptidomics Characterization in Oncology and Infections
by: Pablo Juanes-Velasco, et al.
Published: (2021-05-01)

Elucidation of the signatures of proteasome-catalysed peptide splicing
by: Paes, W, et al.
Published: (2020)

Corrigendum: Elucidation of the Signatures of Proteasome-Catalysed Peptide Splicing
by: Wayne Paes, et al.
Published: (2021-09-01)

Identification of novel mycobacterial antigens presented by MHC-I and -II by immunopeptidomics for vaccines against tuberculosis
by: Bettencourt, P, et al.
Published: (2019)

MS-rescue: a computational pipeline to increase the quality and yield of immunopeptidomics experiments
by: Andreatta, M, et al.
Published: (2019)

Novel insights into the HLA class I immunopeptidome and T-cell immunosurveillance
by: Cornelis J. M. Melief, et al.
Published: (2017-05-01)

Identification of immunodominant HIV-1 epitopes presented by 2 HLA-C*12:02, a protective allele, using an immunopeptidomics 3 approach
by: Chikata, T, et al.
Published: (2019)

Immunopeptidomics reveals determinants of Mycobacterium tuberculosis antigen presentation on MHC class I
by: Owen Leddy, et al.
Published: (2023-04-01)

Immunopeptidomic Analysis of BoLA-I and BoLA-DR Presented Peptides from <i>Theileria parva</i> Infected Cells
by: Timothy Connelley, et al.
Published: (2022-11-01)

Thermostability profiling of MHC-bound peptides: a new dimension in immunopeptidomics and aid for immunotherapy design
by: Emma C. Jappe, et al.
Published: (2020-12-01)

140 Development of first-in-class ERAP2 inhibitors to modulate the cancer immunopeptidome
by: Peter Joyce, et al.
Published: (2023-11-01)

Immunoprecipitation methods impact the peptide repertoire in immunopeptidomics
by: Marcel Wacker, et al.
Published: (2023-07-01)

Birinapant Reshapes the Tumor Immunopeptidome and Enhances Antigen Presentation
by: Weiyan Zhang, et al.
Published: (2024-03-01)

Editorial: Immunopeptidomic Approaches for the Identification of Tumor (neo)Antigens
by: Jennie R. Lill, et al.
Published: (2022-05-01)

The HLA class-II immunopeptidomes of AAV capsids proteins
by: Carlos A. Brito-Sierra, et al.
Published: (2022-12-01)

The HLA class I immunopeptidomes of AAV capsid proteins
by: Carlos A. Brito-Sierra, et al.
Published: (2023-08-01)

Predicting peptide presentation by major histocompatibility complex class I: an improved machine learning approach to the immunopeptidome
by: Kevin Michael Boehm, et al.
Published: (2019-01-01)

Workflow enabling deepscale immunopeptidome, proteome, ubiquitylome, phosphoproteome, and acetylome analyses of sample-limited tissues
by: Jennifer G. Abelin, et al.
Published: (2023-04-01)

TOFIMS mass spectrometry-based immunopeptidomics refines tumor antigen identification
by: Naomi Hoenisch Gravel, et al.
Published: (2023-11-01)

Erratum: The HLA class-II immunopeptidomes of AAV capsids proteins
by: Frontiers Production Office
Published: (2023-07-01)

Molecular Determinants Regulating the Plasticity of the MHC Class II Immunopeptidome
by: Laura Santambrogio, et al.
Published: (2022-05-01)

Contribution of proteasome-catalyzed peptide cis-splicing to viral targeting by CD8+ T cells in HIV-1 infection
by: Paes, W, et al.
Published: (2019)

Variations in MHC class I antigen presentation and immunopeptidome selection pathways [version 1; peer review: 3 approved]
by: Anita J. Zaitouna, et al.
Published: (2020-09-01)

Natural and cryptic peptides dominate the immunopeptidome of atypical teratoid rhabdoid tumors
by: Martin Ebinger, et al.
Published: (2021-10-01)

Therapeutic Cancer Vaccination with Immunopeptidomics-Discovered Antigens Confers Protective Antitumor Efficacy
by: Karita Peltonen, et al.
Published: (2021-07-01)

Immunopeptidomics-Guided Warehouse Design for Peptide-Based Immunotherapy in Chronic Lymphocytic Leukemia
by: Annika Nelde, et al.
Published: (2021-07-01)

Obesity Reshapes Visceral Fat-Derived MHC I Associated-Immunopeptidomes and Generates Antigenic Peptides to Drive CD8+ T Cell Responses
by: Xiaoling Chen, et al.
Published: (2020-04-01)

553 First-in-class inhibitors of ERAP1 alter the immunopeptidome of cancer, driving a differentiated T cell response leading to tumor growth inhibition
by: Peter Joyce, et al.
Published: (2021-11-01)

Current perspectives on mass spectrometry-based immunopeptidomics: the computational angle to tumor antigen discovery
by: Bing Zhang, et al.
Published: (2023-10-01)

BamQuery: a proteogenomic tool to explore the immunopeptidome and prioritize actionable tumor antigens
by: Maria Virginia Ruiz Cuevas, et al.
Published: (2023-08-01)

Neoantigen characteristics in the context of the complete predicted MHC class I self-immunopeptidome
by: Scott D. Brown, et al.
Published: (2019-03-01)

Immunopeptidomics toolkit library (IPTK): a python-based modular toolbox for analyzing immunopeptidomics data
by: Hesham ElAbd, et al.
Published: (2021-08-01)

Adaptation of HIV-1 to human leukocyte antigen class I.
by: Kawashima, Y, et al.
Published: (2009)

Consequences of drug binding to immune receptors: Immune stimulation following pharmacological interaction with immune receptors (T-cell receptor for antigen or human leukocyte antigen) with altered peptide-human leukocyte antigen or peptide
by: Werner J. Pichler
Published: (2013-12-01)